As advancements in systemic therapy continue to improve survival of patients with metastatic cancer, the frequency of patients requiring radiation therapy for treatment of brain metastases has increased. Radiotherapeutic management of brain metastases can range from radiosurgery to whole brain radiation with or without hippocampal sparing. What are some of the considerations in selecting patients for stereotactic radiotherapy, and what dose fractionations should we use? How should we approach and contour leptomeningeal disease, skull metastases and the hippocampus? How do we differentiate post-treatment radiation changes from disease progression on surveillance imaging?

​

Join us for this session as we learn from our panel of international and local experts about the management of brain metastases.